Published in Cancer Causes Control on January 01, 2001
Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ (2007) 8.00
The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis (2010) 2.96
Minireview: Obesity and breast cancer: the estrogen connection. Endocrinology (2009) 2.57
Adiponectin and cancer: a systematic review. Br J Cancer (2006) 2.33
Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer (2005) 2.33
Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer (2007) 2.23
A meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer (2003) 2.02
Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer (2008) 2.01
The role of adiponectin in cancer: a review of current evidence. Endocr Rev (2012) 1.78
Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev (2008) 1.77
Epidemiology of cancer of the small intestine. World J Gastrointest Oncol (2011) 1.75
Risk of cancer following hospitalization for type 2 diabetes. Oncologist (2010) 1.75
The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology. J Gastroenterol (2009) 1.67
Non-viral causes of hepatocellular carcinoma. World J Gastroenterol (2010) 1.63
The association between metabolic syndrome and hepatocellular carcinoma: systemic review and meta-analysis. J Clin Gastroenterol (2014) 1.57
Possible genomic imprinting of three human obesity-related genetic loci. Am J Hum Genet (2005) 1.54
The epidemiology and pathogenesis of neoplasia in the small intestine. Ann Epidemiol (2009) 1.50
Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer. J Gastroenterol (2009) 1.34
Obesity and immune cell counts in women. Metabolism (2007) 1.31
Obesity and the risk of gallbladder cancer: a meta-analysis. Br J Cancer (2007) 1.28
Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk. Cancer Res (2008) 1.28
Visceral adiposity, insulin resistance and cancer risk. Diabetol Metab Syndr (2011) 1.26
Adipocytokines and liver disease. J Gastroenterol (2008) 1.25
Metabolic syndrome and cancer. Metab Syndr Relat Disord (2009) 1.24
Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myeloma. Oncologist (2010) 1.22
Associations between anthropometry, cigarette smoking, alcohol consumption, and non-Hodgkin lymphoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Epidemiol (2010) 1.21
Interacting genetic loci on chromosomes 20 and 10 influence extreme human obesity. Am J Hum Genet (2002) 1.21
Some life-style factors and the risk of invasive epithelial ovarian cancer in Swedish women. Eur J Epidemiol (2004) 1.20
Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection. World J Gastroenterol (2010) 1.19
Excess body weight and obesity--the link with gastrointestinal and hepatobiliary cancer. Nat Rev Gastroenterol Hepatol (2011) 1.18
The conserved NAD(H)-dependent corepressor CTBP-1 regulates Caenorhabditis elegans life span. Proc Natl Acad Sci U S A (2009) 1.14
The role of the fat mass and obesity associated gene (FTO) in breast cancer risk. BMC Med Genet (2011) 1.12
Hepatocellular carcinoma: natural history, current management, and emerging tools. Biologics (2012) 1.10
Body size, recreational physical activity, and B-cell non-Hodgkin lymphoma risk among women in the California teachers study. Am J Epidemiol (2009) 1.06
Leptin and Adiponectin: new players in the field of tumor cell and leukocyte migration. Cell Commun Signal (2009) 1.04
Body mass, tobacco smoking, alcohol drinking and risk of cancer of the small intestine--a pooled analysis of over 500,000 subjects in the Asia Cohort Consortium. Ann Oncol (2011) 1.03
Small bowel adenocarcinomas--existing evidence and evolving paradigms. Nat Rev Clin Oncol (2013) 0.99
Potential role of leptin expression in hepatocellular carcinoma. J Clin Pathol (2006) 0.99
Energy balance feasibility study for Latinas in Texas: a qualitative assessment. Prev Chronic Dis (2007) 0.99
Body mass index and cancer incidence: the FINRISK study. Eur J Epidemiol (2014) 0.98
Body size and the risk of biliary tract cancer: a population-based study in China. Br J Cancer (2008) 0.98
Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma. Blood (2010) 0.97
Potential role of leptin, adiponectin and three novel adipokines--visfatin, chemerin and vaspin--in chronic hepatitis. Mol Med (2011) 0.95
Overweight is associated with improved cancer-specific survival in patients with organ-confined renal cell carcinoma. J Cancer Res Clin Oncol (2009) 0.95
Temporal trends in population-based death rates associated with chronic liver disease and liver cancer in the United States over the last 30 years. Cancer (2014) 0.94
Non-viral factors contributing to hepatocellular carcinoma. World J Hepatol (2013) 0.93
Anti-cancer role of SPARC, an inhibitor of adipogenesis. Cancer Treat Rev (2011) 0.93
Leptin in hepatocellular carcinoma. World J Gastroenterol (2010) 0.93
Adipocytokines and squamous cell carcinoma of the esophagus. J Cancer Res Clin Oncol (2009) 0.91
Energy balance, the PI3K-AKT-mTOR pathway genes, and the risk of bladder cancer. Cancer Prev Res (Phila) (2010) 0.91
Inflammaging and cancer: a challenge for the Mediterranean diet. Nutrients (2015) 0.91
Resistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activation of p38 MAPK/ NFκB signaling pathway in gastric cancer cells. J Biomed Sci (2014) 0.90
The effects of body mass index on complications and survival outcomes in patients with cervical carcinoma undergoing curative chemoradiation therapy. Cancer (2010) 0.89
Carcinoembryonic antigen level can be overestimated in metabolic syndrome. J Korean Med Sci (2011) 0.89
Effect of chronic and intermittent calorie restriction on serum adiponectin and leptin and mammary tumorigenesis. Cancer Prev Res (Phila) (2011) 0.89
Genome-wide interaction study of smoking and bladder cancer risk. Carcinogenesis (2014) 0.87
Risk factors for breast cancer and expression of insulin-like growth factor-2 (IGF-2) in women with breast cancer in Wuhan City, China. PLoS One (2012) 0.86
DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk. Mol Cancer (2008) 0.86
Adiponectin pathway polymorphisms and risk of breast cancer in African Americans and Hispanics in the Women's Health Initiative. Breast Cancer Res Treat (2013) 0.86
Overweight, obesity and meningioma risk: a meta-analysis. PLoS One (2014) 0.86
Height and body mass index in relation to cancer of the small intestine in two million Norwegian men and women. Br J Cancer (2005) 0.86
Esophageal adenocarcinoma and obesity: peritumoral adipose tissue plays a role in lymph node invasion. Oncotarget (2015) 0.86
Microbiome and cancer. Semin Immunopathol (2014) 0.85
Hepatocellular carcinoma in Asia: Prevention strategy and planning. World J Hepatol (2015) 0.85
Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma. J Urol (2011) 0.85
Mild obesity, physical activity, calorie intake, and the risks of cervical intraepithelial neoplasia and cervical cancer. PLoS One (2013) 0.85
Excess body mass index and risk of liver cancer: a nonlinear dose-response meta-analysis of prospective studies. PLoS One (2012) 0.85
Leptin inhibits hepatocellular carcinoma proliferation via p38-MAPK-dependent signalling. HPB (Oxford) (2011) 0.84
Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD. Dig Dis Sci (2016) 0.84
Insulin resistance and other metabolic risk factors in the pathogenesis of hepatocellular carcinoma. Clin Liver Dis (2011) 0.84
Aging and adipose tissue: potential interventions for diabetes and regenerative medicine. Exp Gerontol (2016) 0.83
Changed adipocytokine concentrations in colorectal tumor patients and morbidly obese patients compared to healthy controls. BMC Cancer (2012) 0.83
Obesity and risk of pancreatic cancer among postmenopausal women: the Women's Health Initiative (United States). Br J Cancer (2008) 0.83
Body Mass Index and Risk of Gallbladder Cancer: Systematic Review and Meta-Analysis of Observational Studies. Nutrients (2015) 0.83
Five common haplotype-tagging variants of adiponectin (ADIPOQ) and cancer susceptibility: a meta-analysis. Genet Test Mol Biomarkers (2014) 0.82
Diabetes mellitus and metformin in hepatocellular carcinoma. World J Gastroenterol (2016) 0.82
Adiponectin receptor 2 is negatively associated with lymph node metastasis of colorectal cancer. Oncol Lett (2012) 0.82
Association of body mass index with chromosome damage levels and lung cancer risk among males. Sci Rep (2015) 0.82
Microbiota and nonalcoholic steatohepatitis. Semin Immunopathol (2013) 0.82
Statins and the risk of gastric cancer in diabetes patients. BMC Cancer (2012) 0.82
Prognostic factors in patients with advanced cholangiocarcinoma: role of surgery, chemotherapy and body mass index. World J Gastroenterol (2008) 0.81
Relationship between Metabolic Syndrome and History of Cervical Cancer among a US National Population. ISRN Oncol (2013) 0.81
Polymorphisms in DNA repair pathway genes, body mass index, and risk of non-Hodgkin lymphoma. Am J Hematol (2013) 0.81
Epidemiological aspects of gastric adenocarcinoma: are predictive diagnostics and targeted preventive measures possible? EPMA J (2010) 0.80
B-cell chronic lymphocytic leukemia risk in association with serum leptin and adiponectin: a case-control study in Greece. Cancer Causes Control (2010) 0.80
The association between BMI and gallbladder cancer risk: a meta-analysis. Oncotarget (2016) 0.80
International trends in primary liver cancer incidence from 1973 to 2007. BMC Cancer (2015) 0.80
Serum CA125 concentration has inverse correlation with metabolic syndrome. J Korean Med Sci (2011) 0.79
Multicentric occurrence of hepatocellular carcinoma with nonalcoholic steatohepatitis. World J Hepatol (2011) 0.79
Obesity and Risk for Brain/CNS Tumors, Gliomas and Meningiomas: A Meta-Analysis. PLoS One (2015) 0.78
Prohibitin-induced, obesity-associated insulin resistance and accompanying low-grade inflammation causes NASH and HCC. Sci Rep (2016) 0.78
Combination of body mass index and oxidized low density lipoprotein receptor 1 in prognosis prediction of patients with squamous non-small cell lung cancer. Oncotarget (2015) 0.78
Metabolic syndrome-breast cancer link varies by intrinsic molecular subtype. Diabetol Metab Syndr (2014) 0.78
Impact of body mass index on the oncological outcomes of patients treated with radical cystectomy for muscle-invasive bladder cancer. World J Urol (2016) 0.78
Revisiting the role of antiandrogen strategies in ovarian cancer. Oncologist (2011) 0.77
Three ADIPOR1 Polymorphisms and Cancer Risk: A Meta-Analysis of Case-Control Studies. PLoS One (2015) 0.77
Body size and risk of Hodgkin's lymphoma by age and gender: a population-based case-control study in Connecticut and Massachusetts. Cancer Causes Control (2012) 0.77
Genetic polymorphism of the human organic solute carrier protein 1 (hOSCP1) gene in Japanese patients with non-viral liver carcinoma. Meta Gene (2014) 0.76
Dietary glycemic load, glycemic index, and carbohydrates on the risk of primary liver cancer among Chinese women and men. Ann Oncol (2012) 0.76
"Weighing the risk": Obesity and outcomes following liver transplantation. World J Hepatol (2015) 0.76
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med (1999) 17.30
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (1990) 16.68
Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA (1991) 11.53
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (1998) 10.17
Rising incidence of renal cell cancer in the United States. JAMA (1999) 9.57
The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 9.40
Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature (2000) 8.96
Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res (1988) 7.30
Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med (1969) 6.54
A cancer family syndrome in twenty-four kindreds. Cancer Res (1988) 6.39
Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science (1999) 5.09
The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81
Solid cancers after bone marrow transplantation. N Engl J Med (1997) 4.62
Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst (1993) 4.59
Snuff dipping and oral cancer among women in the southern United States. N Engl J Med (1981) 4.33
Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1997) 4.09
Selection of controls in case-control studies. I. Principles. Am J Epidemiol (1992) 3.94
Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology (1995) 3.86
Selection of controls in case-control studies. II. Types of controls. Am J Epidemiol (1992) 3.80
Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med (2000) 3.72
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1998) 3.66
Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. JAMA (1986) 3.63
Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst (1997) 3.57
The economic cost of brain disorders in Europe. Eur J Neurol (2012) 3.53
Risk of cancer in renal-transplant recipients. Lancet (1973) 3.36
Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ (1998) 3.34
Skin and hair follicle integrity is crucially dependent on beta 1 integrin expression on keratinocytes. EMBO J (2000) 3.32
Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med (1999) 3.31
Cancer risk in users of calcium channel blockers. Hypertension (1997) 3.30
Acetaminophen, aspirin, and chronic renal failure. N Engl J Med (2001) 3.28
Second cancers after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst (1996) 3.26
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22
Helicobacter pylori infection in Swedish school children: lack of evidence of child-to-child transmission outside the family. Gastroenterology (2001) 3.17
Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst (1999) 3.13
Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol (1997) 3.10
Splenectomy and subsequent mortality in veterans of the 1939-45 war. Lancet (1977) 3.05
Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA (1997) 3.00
Clues to cancer etiology from studies of farmers. Scand J Work Environ Health (1992) 2.98
Selection of controls in case-control studies. III. Design options. Am J Epidemiol (1992) 2.88
Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst (1995) 2.83
Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst (1997) 2.83
Interleukin-6 response of epithelial cell lines to bacterial stimulation in vitro. Infect Immun (1992) 2.82
Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst (1996) 2.78
Recent cancer trends in the United States. J Natl Cancer Inst (1995) 2.76
Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol (1996) 2.73
Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA (1993) 2.71
The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA (1995) 2.68
Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer (1999) 2.66
Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol (1998) 2.65
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65
The changing epidemiology of esophageal cancer. Semin Oncol (1999) 2.65
Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology (1993) 2.64
A population-based case-control study of childhood leukemia in Shanghai. Cancer (1988) 2.59
The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer (2000) 2.58
Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA (1998) 2.55
Rapid healing of duodenal ulcers with omeprazole: double-blind dose-comparative trial. Lancet (1983) 2.51
Arsenic and respiratory cancer in man: an occupational study. J Natl Cancer Inst (1969) 2.50
International trends and patterns of primary liver cancer. Int J Cancer (2001) 2.50
Reliability of surrogate information on cigarette smoking by type of informant. Am J Epidemiol (1987) 2.49
Tobacco use and prostate cancer: 26-year follow-up of US veterans. Am J Epidemiol (1991) 2.49
Geographic patterns of lung cancer: industrial correlations. Am J Epidemiol (1976) 2.45
Rheumatoid arthritis and cancer risk. Eur J Cancer (1996) 2.44
Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer (2003) 2.43
Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (1998) 2.43
Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev (2002) 2.36
Appendectomy and subsequent risk of inflammatory bowel diseases. Surgery (2001) 2.35
Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery. Gastroenterology (2001) 2.34
Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst (2000) 2.32
Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors. Am J Epidemiol (2001) 2.30
Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J Natl Cancer Inst (1969) 2.30
Inverse association between intake of cereal fiber and risk of gastric cardia cancer. Gastroenterology (2001) 2.30
Declining lung cancer rates among young men and women in the United States: a cohort analysis. J Natl Cancer Inst (1989) 2.28
Cancer mortality among chemists. J Natl Cancer Inst (1969) 2.28
Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res (1990) 2.21
Acute leukemia after alkylating-agent therapy of ovarian cancer. N Engl J Med (1977) 2.20
AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology (1998) 2.19
Fluoridated drinking water and the occurrence of cancer. J Natl Cancer Inst (1976) 2.19
Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroenterol (2000) 2.18
A population--based case--control study of renal cell carcinoma. J Natl Cancer Inst (1984) 2.17
No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut (2000) 2.16
Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst (1998) 2.13
Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (2001) 2.13
Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. J Natl Cancer Inst (1997) 2.12
Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst (1987) 2.12
Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. J Natl Cancer Inst (1976) 2.11
Cellular telephones and risk for brain tumors: a population-based, incident case-control study. Neurology (2005) 2.11
Risk factors for esophageal cancer in Shanghai, China. I. Role of cigarette smoking and alcohol drinking. Int J Cancer (1994) 2.09